|

Aspirin and low-dose rivaroxaban Clinical Trials

1 actively recruiting trial

Also known as: Aspirin + low-dose rivaroxaban (2.5mg bid)

Pipeline

Phase 4: 1

Top Sponsors

  • Seoul National University Bundang Hospital1

Indications

  • Cardiac Event1
  • Peripheral Artery Disease1
  • Heart Disease1
  • Coronary Artery Disease1
  • Bleeding1

Other1 trial

Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.